Article and Video CATEGORIES

Cancer Journey

Search By

Clinical Trials Experiences Through Storytelling - Melinda Bachini - The Miracle of a Clinical Trial
Melinda Bachini - Nothing to Lose and Everything to Gain - The Miracle of a Clinical Trial
Author
GRACE Videos and Articles
Image
Melinda Bachini

We are proud to present this series on Clinical Trials Experiences.


This unique patient education program gives a voice to patients with experience in participating in a clinical trial. Through storytelling and sharing their experiences, patients can educate others who are considering a similar journey.

 

In this video, Melinda Bachini, a 12-year survivor discusses her next steps and finding a clinical trial for cholangiocarcinoma.

 

Many thanks to our sponsors! #Exelixis #Novartis #Merck #Lilly

Image
exelixis, merck, novartis, lilly

To join the conversation, visit https://cancergrace.org/forums/gall-bladder-and-bile-duct-cancer-cholan…

Video Language

Next Previous link

Previous PostNext Post

Related Content

Article
Las biopsias líquidas están revolucionando la forma en que combatimos el cáncer, ofreciendo un futuro donde la detección y el tratamiento son más rápidos, precisos y menos invasivos.
Image
Videoteca de Cáncer de Pulmon - 2025
Video
Como parte de la Videoteca de Cáncer de Pulmón en Español 2025, oncólogos expertos discuten las opciones de tratamiento y la información más emergente en cáncer de pulmón. El Dr. Raez aborda la terapia para cánceres de pulmón EGFR y ALK, además de analizar otros tres temas de actualidad. La Dra. Viola y la Dra. Riaño también contribuyen a esta videoteca, cada una presentando tres temas relevantes sobre el cáncer de pulmón.
Article
The journey to conquer lung cancer is paved with scientific discovery, and the identification of the EGFR and ALK genes as crucial players marks a significant milestone. Unraveling how mutations in these seemingly small segments of our DNA can unleash the destructive force of cancer has opened up exciting new therapeutic avenues. This exploration delves into the cutting-edge world of EGFR and ALK-targeted therapies, highlighting the progress made and the ongoing quest for even more effective and personalized strategies to combat this formidable disease.